Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is

Front Cardiovasc Med. 2022 Oct 18:9:1034095. doi: 10.3389/fcvm.2022.1034095. eCollection 2022.

¹ Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.

No abstract available

Keywords: cardiovascular; death; glucagon-like peptide 1 receptor agonists; heart failure; sodium-glucose cotransporter 2 inhibitors; stroke.